摘要 |
The present invention features processes for preparing compounds, such as (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2- (1 -hydroxy-2-methylpropan-2-yl)- 1H-indol-5 -yl)cyclopropanecarboxamide (Compound 1 ), useful for treating CFTR mediated diseases such as cystic fibrosis. |
申请人 |
VERTEX PHARMACEUTICALS INCORPORATED;TANOURY, GERALD, J.;HARRISON, CRISTIAN;LITTLER, BENJAMIN, JOSEPH;ROSE, PETER, JAMISON;HUGHES, ROBERT, MICHAEL;JUNG, YOUNG CHUN;SIESEL, DAVID, ANDREW;LEE, ELAINE, CHUNGMIN;BELMONT, DANIEL, T. |
发明人 |
TANOURY, GERALD, J.;HARRISON, CRISTIAN;LITTLER, BENJAMIN, JOSEPH;ROSE, PETER, JAMISON;HUGHES, ROBERT, MICHAEL;JUNG, YOUNG CHUN;SIESEL, DAVID, ANDREW;LEE, ELAINE, CHUNGMIN;BELMONT, DANIEL, T. |